Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-Acetylcysteine for Cocaine Dependence
NCT02141620Phase 1Completed
- Sponsor
- University of Kentucky
- Start
- May 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetylcysteine in cocaine dependence, sponsored by University of Kentucky. Primary endpoint: Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative at 2 weeks. Started May 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT02141620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141620.